Bilirubin Blood Test Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, France, China - Size and Forecast 2024-2028

Bilirubin Blood Test Market Size 2024-2028

The bilirubin blood test market size is forecast to increase by USD 552.66 million at a CAGR of 6.24% between 2023 and 2028.

• The market is witnessing significant growth due to several key factors. The increasing prevalence of jaundice and liver diseases worldwide is driving market demand. Additionally, the trend towards non-invasive blood bilirubin procedures is gaining traction, as these methods offer advantages such as reduced pain and fewer complications compared to traditional invasive tests. Bilirubin can also be found in bile and dark urine, and its elevated levels can indicate various liver conditions such as hepatitis, liver diseases, and gallbladder issues. However, the high costs associated with these tests remain a challenge, limiting accessibility to some patients. Overall, the market is expected to experience steady growth In the coming years, as advancements in technology and increasing awareness of the importance of early diagnosis and treatment drive demand.

What will be the Size of the Bilirubin Blood Test Market During the Forecast Period?

 Request Free Sample

• The market encompasses diagnostic techniques used to measure bilirubin levels in a patient's blood. Bilirubin is a yellow pigment produced during the breakdown of old red blood cells, and its accumulation can lead to jaundice, characterized by yellowing of the skin and eyes. The market includes both transcutaneous and bench-top bilirubin tests, catering to diverse healthcare settings, including hospitals and diagnostic laboratories.
• Furthermore, factors driving market growth include the increasing prevalence of liver diseases, heme disorders like anemia, and the growing health awareness among populations. The COVID-19 pandemic has also led to a growth in demand for diagnostic tests, including bilirubin blood tests, as healthcare workers prioritize early detection and treatment of various conditions. The market comprises total bilirubin and indirect bilirubin tests, used to diagnose a range of liver illnesses, including Gilbert's syndrome, hemolytic anemia, and other bilirubin-related disorders.

How is this Bilirubin Blood Test Industry segmented and which is the largest segment?

The bilirubin blood test industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in "USD million" for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

• End-user
  • Infants
  • Adults
• Product Type
  • Instruments
  • Consumables
• Geography
  • North America
    • US
  • Europe
    • Germany
    • UK
    • France
  • Asia
    • China
  • Rest of World (ROW)

By End-user Insights

• The infants segment is estimated to witness significant growth during the forecast period.

The infant segment dominates The market due to the high incidence of neonatal jaundice. Factors driving market growth include increasing new product launches, government initiatives to raise awareness about neonatal jaundice, and the presence of prominent players with extensive product offerings. Notably, neonatal jaundice affects approximately 80% of premature infants according to the Centers for Disease Control and Prevention (CDC). Bilirubin blood tests are essential for diagnosing and monitoring jaundice, which can lead to complications such as kernicterus if left untreated. These tests measure the levels of unconjugated and total bilirubin In the blood. Various diagnostic techniques are available, including transcutaneous, bench-top, and hospital-based tests.

Bilirubin testing instruments include analyzers, meters, and portable testing kits. The market includes key players providing consumables, instruments, and analyzers, such as medical agencies, diagnostics centers, research laboratories, academic institutions, pediatric clinics, and child specialist hospitals. Bilirubin tests are also used for diagnosing conditions like hepatitis, liver diseases, anemia, and Gilbert's syndrome. Healthcare workers and patients rely on these tests to monitor liver conditions and diagnose complications related to dark urine, yellowing of the skin and eyes, and gallbladder issues. Bilirubin testing is crucial for early detection and treatment, contributing significantly to the overall healthcare sector.

Get a glance at the  Bilirubin Blood Test Industry report of share of various segments Request Free Sample

The infants segment was valued at USD 796.50 million in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

• North America is estimated to contribute 38% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American market is projected to expand due to technological advancements in testing products, rising prevalence of chronic liver diseases and jaundice, and extensive insurance coverage In the region. Neonatal jaundice and liver diseases, which impair the ability to metabolize and excrete bilirubin, are significant drivers for market growth. Bilirubin tests are essential for diagnosing various liver conditions, including hepatitis and jaundice, as well as hemolytic anemia and Gilbert's syndrome. This diagnostic technique is utilized in pediatric clinics, child specialist hospitals, research laboratories, and diagnostic centers.

Moreover, bilirubin testing instruments, consumables, and analyzers, including transcutaneous, bench-top, and portable testing kits, are employed by medical agencies and healthcare workers for accurate and timely diagnosis. Key applications include unconjugated bilirubin tests, total bilirubin tests, direct bilirubin tests, and indirect bilirubin tests. The market expansion is fueled by the growing health awareness and the need for early detection and treatment of liver conditions.

Market Dynamics

Our researchers analyzed the data with 2023 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise In the adoption of Bilirubin Blood Test Industry?

Increasing prevalence of jaundice and liver diseases is the key driver of the market.

• Bilirubin blood tests play a crucial role in diagnosing various liver conditions, including jaundice, hepatitis, and liver diseases. Bilirubin is a yellow pigment produced when hemoglobin in red blood cells is broken down. Elevated levels of bilirubin can lead to jaundice, which is characterized by yellowing of the skin and eyes, as well as dark urine. Neonatal jaundice, a common condition in newborns, is a significant driver of the market. This condition affects up to 60% of term and 80% of preterm infants and can lead to serious complications if left untreated. Bilirubin tests are essential in diagnosing liver conditions, including those caused by coronavirus and respiratory problems.
• The market for bilirubin blood tests is expected to grow due to the increasing awareness of health issues and the availability of advanced diagnostic technologies. Medical agencies, pediatric clinics, child specialist hospitals, and research laboratories are significant consumers of bilirubin testing kits, consumables, instruments, analyzers, and bilirubin meters. Portable testing kits have gained popularity due to their convenience and ease of use, making bilirubin testing accessible to healthcare workers in remote areas. The market for bilirubin blood tests includes various diagnostic techniques, such as Unconjugated Bilirubin Test, Total Bilirubin Test, Direct Bilirubin Test, and Indirect Bilirubin Test. Bilirubin testing is also used In the diagnosis of conditions like Gilbert's syndrome, hemolytic anemia, and heme disorders.
• In summary, the market is expected to grow significantly due to the increasing prevalence of liver conditions, the high incidence of neonatal jaundice, and the availability of advanced diagnostic technologies. The market caters to various end-users, including pediatric clinics, diagnostic centers, research laboratories, and academic institutions. The use of portable testing kits and the development of new diagnostic technologies are expected to further drive market growth.

What are the market trends shaping the Bilirubin Blood Test Industry?

Increasing demand for non-invasive blood bilirubin procedures is the upcoming market trend.

• The market encompasses various diagnostic techniques and technologies used to measure bilirubin levels in patients, particularly those suffering from liver conditions such as jaundice, hepatitis, and anemia. Bilirubin is a yellow pigment produced during the breakdown of old red blood cells, and its levels can indicate liver function and hemolytic anemia. The demand for non-invasive testing methods is on the rise due to their convenience, minimal discomfort, and reduced risk of infections. Non-invasive bilirubin testing includes methods like transcutaneous, bench-top, and portable testing kits, which are increasingly preferred over traditional blood tests. Transcutaneous testing involves measuring bilirubin levels through the skin, while bench-top and portable testing kits offer the convenience of on-site testing in clinics and diagnostic centers.
• Bilirubin testing is crucial for pediatric patients, as jaundice in infants can lead to complications like kernicterus, which can cause hearing loss, developmental delays, and other neurological issues. The market for bilirubin testing consumables, instruments, analyzers, and bilirubin meters is expected to grow significantly due to the increasing awareness of health issues and the need for accurate and timely diagnosis. Bilirubin testing is also essential for patients with liver diseases, coronavirus, and respiratory problems, as these conditions can lead to elevated bilirubin levels. Pathological labs, research laboratories, academic institutions, pediatric clinics, and child specialist hospitals are significant end-users of bilirubin testing technologies.
• In summary, the market is expected to grow significantly due to the increasing demand for non-invasive testing methods, the growing number of patients with liver conditions, and the need for accurate and timely diagnosis. The market comprises various diagnostic techniques, technologies, and end-users, including pediatric patients, liver disease patients, and healthcare workers in clinics, diagnostic centers, and research laboratories.

What challenges does the Bilirubin Blood Test Industry face during its growth?

High costs and complications associated with blood bilirubin testing is a key challenge affecting the industry growth.

• The market encompasses various diagnostic techniques and technologies used for measuring the levels of bilirubin In the blood, primarily for detecting liver conditions such as jaundice in patients, particularly infants. Bilirubin is a yellow pigment produced during the breakdown of hemoglobin In the liver, and its accumulation In the blood can lead to symptoms like dark urine, yellowing of the skin and eyes, and other health issues. Bilirubin tests include Unconjugated Bilirubin Test, Total Bilirubin Test, Direct Bilirubin Test, and Indirect Bilirubin Test. These tests are essential for diagnosing various liver diseases, including hepatitis, anemia, and liver illnesses like Gilbert's syndrome and hemolytic anemia.
• The market comprises various stakeholders, including medical agencies, diagnostic centers, research laboratories, academic institutions, pediatric clinics, and child specialist hospitals. The diagnostic techniques and technologies used In the market include instruments, analyzers, bilirubin meters, and portable testing kits. The cost of transcutaneous bilirubinometers, a non-invasive testing method, is comparatively higher than the conventional blood testing method. This can increase the cost burden on end-users and patients. The cost of these meters ranges between USD3,100 and USD7,000, depending on the technology and brand preference. The high cost of transcutaneous bilirubinometers may impact their adoption and coverage, particularly in developing countries.
• However, the increasing awareness of health issues and the growing demand for non-invasive diagnostic methods may drive the market growth. The market dynamics include the increasing prevalence of liver diseases, the growing demand for non-invasive diagnostic methods, and the technological advancements in diagnostic techniques and instruments. Healthcare workers and clinics are key consumers of these diagnostic technologies, and the market is expected to grow significantly In the coming years.

Exclusive Customer Landscape

The bilirubin blood test market forecasting report includes the adoption lifecycle of the market, market growth and forecasting, covering from the innovator's stage to the laggard's stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the bilirubin blood test market report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their market growth analysis strategies.

 Customer Landscape

Key Companies & Market Insights

Companies are implementing various strategies, such as strategic alliances, bilirubin blood test market forecast, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence In the industry.

The industry research and growth report includes detailed analyses of the competitive landscape of the market and information about key companies, including:

• Abbott Laboratories
• Advanced Instruments LLC
• ALLMEDTECH
• AMETEK Inc.
• Anamol Laboratories Pvt. Ltd.
• BIOGENIX Inc. Pvt. Ltd.
• DiaSys Diagnostic Systems GmbH
• Dragerwerk AG and Co. KGaA
• ELITechGroup SAS
• F. Hoffmann La Roche Ltd.
• GINEVRI Srl
• Jaiprakash Associates Ltd.
• Koninklijke Philips N.V.
• Mega Lab SA
• Merck KGaA
• Micro Lab Instruments
• Randox Laboratories Ltd.
• Siemens AG
• Teco Diagnostics
• Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key industry players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Research Analyst Overview

The market encompasses a diagnostic technique utilized for assessing liver health and detecting various liver conditions. This test measures the levels of bilirubin, a yellow pigment produced during the normal breakdown of old red blood cells, in an individual's bloodstream. Bilirubin is a crucial component In the production of bile, which plays a significant role In the digestive process. Bilirubin exists in two forms: unconjugated and conjugated. Unconjugated bilirubin is the form found In the blood when it is not bound to proteins, while conjugated bilirubin is the form that has been bound to proteins and is ready to be excreted in bile.

Moreover, imbalances In these forms can indicate specific liver conditions. The bilirubin blood test is essential in various medical settings, including pediatrics, diagnostics centers, research laboratories, academic institutions, and child specialist hospitals. In pediatrics, the test is commonly used to diagnose and monitor jaundice in infants, a condition characterized by the yellowing of the skin and eyes due to high levels of bilirubin. In adults, the test is used to diagnose and monitor liver diseases, such as hepatitis, heme disorders, and hemolytic anemia. The bilirubin blood test is performed using various diagnostic technologies, including bench-top analyzers, bilirubin meters, and transcutaneous devices. These tests provide valuable information to healthcare workers, enabling them to make informed decisions regarding patient care and treatment. The market is driven by several factors, including the increasing prevalence of liver diseases, the growing awareness of health issues, and the advancements in diagnostic technologies. The availability of portable testing kits and the convenience they offer have also contributed to the growth of the market. Moreover, the market is expected to continue its growth trajectory due to the increasing demand for early and accurate diagnosis of liver conditions.

Furthermore, the market is also expected to benefit from the rising number of pathological labs and diagnostic centers and the increasing focus on research and development In the field of diagnostics. In summary, the market represents a vital component of the diagnostic industry, providing essential information for the diagnosis and monitoring of various liver conditions. The market is driven by several factors, including the increasing prevalence of liver diseases, the growing awareness of health issues, and the advancements in diagnostic technologies. The market is expected to continue its growth trajectory, driven by the increasing demand for early and accurate diagnosis of liver conditions and the availability of advanced diagnostic technologies.

Request Free Sample

What are the Key Data Covered in this Bilirubin Blood Test Market Research and Growth Report?

• CAGR of the Bilirubin Blood Test industry during the forecast period
• Detailed information on factors that will drive the growth and forecasting between 2024 and 2028
• Precise estimation of the size of the market and its contribution of the industry in focus to the parent market
• Accurate predictions about upcoming growth and trends and changes in consumer behaviour
• Growth of the market across North America, Europe, Asia, and Rest of World (ROW)
• Thorough analysis of the market's competitive landscape and detailed information about companies
• Comprehensive analysis of factors that will challenge the bilirubin blood test market growth of industry companies

We can help! Our analysts can customize this bilirubin blood test market research report to meet your requirements.

Get in touch